Danila Morano

ORCID: 0000-0001-6002-9508
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Prenatal Screening and Diagnostics
  • Assisted Reproductive Technology and Twin Pregnancy
  • Reproductive System and Pregnancy
  • Birth, Development, and Health
  • Ectopic Pregnancy Diagnosis and Management
  • Maternal and fetal healthcare
  • Maternal and Perinatal Health Interventions
  • Cleft Lip and Palate Research
  • Craniofacial Disorders and Treatments
  • Gestational Diabetes Research and Management
  • COVID-19 Impact on Reproduction
  • Pregnancy and Medication Impact
  • Renal and related cancers
  • Neonatal and fetal brain pathology
  • Vascular anomalies and interventions
  • Microscopic Colitis
  • Congenital Heart Disease Studies
  • Central Venous Catheters and Hemodialysis
  • Pregnancy-related medical research
  • Systemic Lupus Erythematosus Research
  • Hip and Femur Fractures
  • Congenital heart defects research
  • Gestational Trophoblastic Disease Studies
  • Bone and Joint Diseases

Magna Graecia University
2025

Anna University, Chennai
2025

University of Ferrara
2010-2024

Arcispedale Sant'Anna
2017-2024

Ospedale Sant'Anna
2019-2024

IRCCS Policlinico San Donato
2022-2023

Istituto Superiore di Sanità
2023

University of Bologna
2006-2011

Daniele Di Mascio Cihat Şen Gabriele Saccone A. Galindo Amos Grünebaum and 95 more Jun Yoshimatsu Milan Stanojević Asım Kurjak Frank A. Chervenak María José Suaréz Zita Maria Gambacorti-Passerini Maria Baz Esther Vanessa Aguilar Galán Yolanda Cuñarro López Juan A. De León-Luis Ignacio Cueto-Hernández Ignacio Herraı̀z Cecilia Villalaín Roberta Venturella Giuseppe Rizzo Ilenia Mappa Giovanni Gerosolima L Hellmeyer J. Königbauer Giada Ameli T. Frusca N. Volpe G. Schera Stefania Fieni Eutalia Esposito Giuliana Simonazzi Gaetana Di Donna A. Youssef Anna Nunzia Della Gatta Mariano Catello Di Donna Vito Chiàntera Natalina Buono Giulio Sozzi Pantaleo Greco Danila Morano Beatrice Bianchi Maria Giulia Marino F. Laraud Arianna Ramone Angelo Cagnacci Fabio Barra Claudio Gustavino Simone Ferrero Fabio Ghezzi Antonella Cromi Antonio Simone Laganà Valentina Laurita Longo Francesca Stollagli Angelo Sirico Antonio Lanzone Lorenza Driul Fabiana Cecchini D Serena Xodo Brian Mondeja Felipe Mercado‐Olivares Deena Elkafrawi Giovanni Sisti Rosanna Esposito Antonio Coviello Marco Cerbone Maddalena Morlando Antonio Schiattarella Nicola Colacurci Pasquale De Franciscis I. Cataneo Marinella Lenzi Fabrizio Sandri Riccardo Buscemi Giorgia Gattei F Sala Eleonora Valori Maria Cristina Rovellotti Elisa Doné Gilles Faron Léonardo Gucciardo Valentina Esposito Flaminia Vena Antonella Giancotti Roberto Brunelli Ludovico Muzii Luigi Nappi Felice Sorrentino Lorenzo Vasciaveo Marco Liberati Danilo Buca Martina Leombroni F. Di Sebastiano Luciano Di Tizio Diego Gazzolo Massimo Piergiuseppe Franchi Quintino Cesare Ianniciello Simone Garzon Giuliano Petriglia Leonardo Borrello Albaro José Nieto‐Calvache

Abstract Objectives To evaluate the strength of association between maternal and pregnancy characteristics risk adverse perinatal outcomes in pregnancies with laboratory confirmed COVID-19. Methods Secondary analysis a multinational, cohort study on all consecutive pregnant women laboratory-confirmed COVID-19 from February 1, 2020 to April 30, 73 centers 22 different countries. A case was defined as positive result real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay...

10.1515/jpm-2020-0355 article EN other-oa Journal of Perinatal Medicine 2020-09-25
Laura Andréoli Maria Chiara Gerardi Maria Gerosa Davide Rozza Francesca Crisafulli and 95 more Roberta Erra Daniele Lini Laura Trespìdi Melissa Padovan Francesca Ruffilli Francesca Serale Giovanna Cuomo Bernd Raffeiner Paolo Semeraro Chiara Tani Maria Sole Chimenti Paola Conigliaro Ariela Hoxha Cecilia Nalli Micaela Fredi Maria Grazia Lazzaroni Matteo Filippini Marco Taglietti Franco Franceschini Sonia Zatti Chiara Loardi Rossana Orabona Francesca Ramazzotto Cristina Zanardini Giulia Fontana G. I. Gozzoli C. Barison P. Bizioli Roberto Caporali Giulia Carrea Manuela Wally Ossola Beatrice Maranini Ettore Silvagni Marcello Govoni Danila Morano Rosita Verteramo Andrea Doria Teresa Del Ross Maria Favarò Antonia Calligaro Marta Tonello Maddalena Larosa Margherita Zen Alessandra Zambon Marta Mosca Dina Zucchi Elena Elefante Sabrina Gori Florenzo Iannone Maria Grazia Anelli Marlea Lavista Anna Abbruzzese Carlo Giuseppe Fasano Salvatore D’Angelo Maria Stefania Cutro Valentina Picerno Teresa Carbone Angela Padula Patrizia Rovere‐Querini Valentina Canti Rebecca De Lorenzo Ludovica Cavallo Véronique Ramoni Carlomaurizio Montecucco Veronica Codullo Alessandra Milanesi Giulia Pazzola Giuseppina Comitini Chiara Marvisi Carlo Salvarani Oscar Massimiliano Epis Sara Benedetti Giuseppina Di Raimondo C. Gagliardi Claudia Lomater G. Crepaldi Elisa Bellis Francesca Bellisai Estrella Garcia Gonzalez Anna Paola Pata Martina Zerbinati Maria Letizia Urban Irene Mattioli Anna Iuliano Gian Domenico Sebastiani Antonio Brucato Emanuele Bizzi Maurizio Cutolo Leonardo Santo S. A. Tonetta Gianpiero Landolfi Greta Carrara Alessandra Bortoluzzi Carlo Alberto Scirè Anǵela Tincani

To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) the Italian prospective cohort study P-RHEUM.it.

10.1136/rmdopen-2024-004091 article EN cc-by-nc RMD Open 2024-04-01

Abstract Background Gastrointestinal Infections (GIs) pose a significant challenge in patients with inflammatory bowel diseases (IBD), complicating its management and triggering IBD relapses. The overlap clinical symptoms makes complex differentiating GIs from flares, impacting therapeutic decisions. This study aims at evaluating the long-term impact of patients. Methods From January 2020 to September 2024, 102 (mean age 45±16 yrs; 78 ulcerative colitis, UC 24 Crohn’s disease, CD)...

10.1093/ecco-jcc/jjae190.0503 article EN Journal of Crohn s and Colitis 2025-01-01

Objective To determine the performance of screening for late pre‐eclampsia (PE) by maternal characteristics, uterine artery Doppler and a set biochemical markers at 11 + 0 to 13 6 weeks' gestation. Methods Prospectively enrolled women weeks. Maternal highest UtA pulsatility index serum placental biomarkers including pregnancy‐associated plasma protein‐A, growth factor, soluble fms‐like tyrosine kinase 1, P‐selectin neutrophil gelatinase‐associated lipocalin were recorded. Results The rate PE...

10.1002/pd.2848 article EN Prenatal Diagnosis 2011-10-28

Objective Prospective assignment at 11 + 0 to 13 6 weeks of risk for late pre‐eclampsia (PE) using eight logistic regression‐based statistical models. Methods Five hundred and fifty‐four pregnancies. Uterine artery pulsatility index, parity, body mass mean arterial pressure, pregnancy‐associated plasma protein‐A, free β‐human chorionic gonadotrophin maternal age, were combined obtain ‘ a posteriori PE’. Results We observed 39 cases (7%) PE. There 12 severe PE 27 mild According the models...

10.1002/pd.2849 article EN Prenatal Diagnosis 2011-10-18

Objective The aim of this study was to evaluate whether the quantitative distribution a panel circulating mRNAs from maternal whole blood normal pregnancies is statistically different those complicated with preeclampsia (PE) or without intrauterine growth restriction (IUGR). Methods Maternal six subjects mild severe PE IUGR and 30 matched controls (1:5 match for gestational age) were retrospectively examined mRNA markers. Seven specific markers identified chosen based on previous microarray...

10.1002/pd.1562 article EN Prenatal Diagnosis 2006-01-01

Abstract Objectives To determine the gene expression profile in chorionic villous samples (CVS) of women destined to develop preeclampsia. Method cDNA microarray technology was employed. Ten singleton fetuses who subsequently developed preeclampsia where compared with a pool 50 controls. The mRNA some genes previously found be up‐ or down‐regulated were validated by RT‐PCR peripheral blood from 23 pregnant at term affected and Results Altered among several including those involved invasion...

10.1002/pd.2344 article EN Prenatal Diagnosis 2009-09-03

To compare, using a unified approach, standardized estimated fetal weight (EFW) trajectories from the second trimester to birth and birth-weight (BW) measurements in in-vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) pregnancies obtained after frozen-thawed vs fresh blastocyst transfer (BT).This was secondary analysis of prospective longitudinal cohort study performed at Fetal Medicine Obstetric Departments San Raffaele Hospital Milan, Italy, January 2016 December 2020....

10.1002/uog.24806 article EN Ultrasound in Obstetrics and Gynecology 2021-10-30

Abstract Objectives To determine the gene expression profile in chorionic villous samples (CVSs) of women destined to develop pre‐eclampsia (PE). Method Case‐control study encompassing five PE [cases matched for gestational age with 30 controls]. We quantified mRNA on tissue from CVS normal and patients. then assessed expressions cathepsin (CTSD), angiopoietin 2 (ANGPT2), interleukin 8, chemokine (C‐X‐C motif) ligand 10, neurokinin B (NKB), matrix metallopeptidase 9, major histocompatibility...

10.1002/pd.2675 article EN Prenatal Diagnosis 2011-01-04

Abstract STUDY QUESTION Do uterine arteries Doppler studies show different pulsatility index (UtA-PI) measurements in IVF/ICSI pregnancies with oocyte donation (OD) as compared to natural conceptions? SUMMARY ANSWER In OD, UtA-PI is reduced by an average of about 40% conception. WHAT IS KNOWN ALREADY OD present worse pregnancy outcomes conception, particularly for increased incidence pre-eclampsia (PE). Recent evidence shows that frozen blastocyst transfer also higher prevalence PE and 15%...

10.1093/humrep/deaa235 article EN Human Reproduction 2020-08-19

Cyclic adenosine 3′-5′-monophosphate (cAMP) is a second messenger, which exerts an important role in the control of human first-trimester trophoblast functions. In present study we demonstrate existence mechanism that able to extrude cAMP from trophoblast-derived cell lines, and show evidence indicating involvement multidrug resistance protein (MRP) 1, transporter belonging ATP-binding cassette family, egress. MRP1 expressed lines efflux highly reduced by inhibitor, MK-571. addition,...

10.1093/molehr/gaq023 article EN Molecular Human Reproduction 2010-03-15

•The use of ICIs is associated with an increased risk developing different forms colitis.•The 12-month clinical outcome ICI-induced colitis and the factors lack remission are poorly known.•A Crohn's disease-like pattern was a worse rate.•Having histopathological signs microscopic better rate. BackgroundData regarding patients immune checkpoint inhibitor (ICI)-induced scant. We aimed to describe colitis.Materials methodsThis retrospective, European, multicentre study....

10.1016/j.esmoop.2024.103632 article EN cc-by-nc-nd ESMO Open 2024-07-01
Coming Soon ...